If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

Share Price is delayed by 15 minutes
Get Live Data
71.00    1.00 (1.43%)
Bid:
69.00
Ask:
73.00
Spread: 4.00 (5.797%)
Market Cap: £67.29m
TPX Live PriceLast checked at - London Stock Exchange

Intraday Tpximpact Hldg Share Chart

Amendment to Share Purchase Agreements

8 Sep 2020 07:01

RNS Number : 2840Y
Panoply Holdings PLC (The)
08 September 2020
Β 

8 September 2020

Β 

The Panoply Holdings PLC

("The Panoply", or the "Group")

Β 

Amendment to Share Purchase Agreements

Β 

The Panoply (AIM: TPX), the technology-enabled services group focused on digital transformation, announces that the Group has entered into various agreements to amend the terms of a number of its historical share purchase agreements ("SPA"). The details of these amendments are set out below.

Β 

In line with the Group's strategy, as announced in its recent Annual Report, to consolidate its end-to-end propositions under two full stack brands, The Panoply has agreed to accelerate the end of the earn-out periods in respect of FutureGov and Ameo with a view facilitating full integration into the Group. Ameo is becoming part of FutureGov, supercharging its change delivery and opening new doors within local and central Government for even bigger impact. Ameo supports its clients through full stack change delivery to build the best outcomes for citizens with long term impact.Β Both Ameo and FutureGov continue to trade strongly in line with expectations.

Β 

The result of these changes, together with the other amendments detailed below, is to increase the total deferred consideration now known to be payable by The Panoply to Β£20,835,794. The maximum further shares to be issued as a result of this consideration is 26,395,283, which reduces to 18,719,658 assuming the share price remained constant at 130p, being the closing mid market price on the day prior to this announcement.

Β 

SPA for the acquisition of the entire issued share capital of FutureGov Ltd ("FG") dated 11 June 2019 (the "FG SPA")Β 

The parties to the FG SPA have agreed that the FG sellers will receive deferred earn-out consideration equal to a fixed amount of Β£1,249,290 in respect of the 12 month period ending on 31 March 2021.

Β 

The FG SPA has been amended so that this amount is to be paid inΒ substitution for amounts that were previously to have been determined by a calculation that was predominantly based on FG's EBITDA performance for the period to 31 March 2021 ("FG Reference Period").Β Β Otherwise the terms of the original FG SPA are not substantially changed, including in respect of the proportion of consideration payable as ordinary shares in the Panoply (96%) ("Panoply Shares") and cash (4%).

Β 

Further, the number of Panoply Shares to be issued and allotted continues to be calculated by dividing the earn-out price payable by the greater of 83.125 pence and the volume-weighted average mid-market price ("VWAP") over the 30 business days prior to the issue of the relevant Panoply Shares. The timing of the issue and allotment of these Panoply Shares also remains unchanged, being in four tranches following the publication of the accounts of the Panoply for the relevant FG Reference Period.

Β 

The cash element of the deferred earn-out consideration, being Β£121,136.40, will be paid by the Panoply within 10 business days of this announcement.Β 

Β 

SPA for the acquisition of the entire issued share capital of AMEO Professional Services Limited ("Ameo") dated 10 March 2020 (the "Ameo SPA")

Β 

The parties to the Ameo SPA have agreed that the Ameo sellers will receive deferred earn-out consideration equal to fixed amounts of:Β 

Β 

1. Β£416,460 in respect of the 17 month period ending on 31 March 2021 and;Β 

2. Β£889,710 in respect of the 12 month period ending on 31 March 2022.

Β 

The Ameo SPA has been amended so that these amounts are to be paid in substitution for amounts that were previously to have been determined by a calculation that was predominantly based on Ameo's EBITDA performance for each of these periods (each an "Ameo Reference Period").Β Otherwise the terms of the Ameo SPA are not substantially changed and the number of Panoply Shares to be issued and allotted remains calculated by dividing the earn-out price payable by Β the greater of 82 pence and the VWAP over the 30 business days prior to the issue of the relevant Panoply Shares. The timing of the issue and allotment of these Panoply Shares also remains unchanged, being in one tranche following the publication of the Panoply's accounts for the relevant Ameo Reference Period.Β 

Β 

SPA for the acquisition of the entire issued share capital of Greenshoot Labs Limited ("GSL") dated 11 February 2019 (the "GSL SPA")

Β 

The parties to the GSL SPA have agreed that the GSL sellers will receive deferred earn-out consideration equal to a fixed amount of Β£500,000 in respect of the 12 month period ending on 31 March 2020 (the "First GSL Reference Period"), in substitution for an amount that would have been previously determined by a calculation predominantly based on GSL's EBITDA performance for the First GSL Reference Period.Β This is to reflect the value of GSL's revenue growth during the period.

Β 

The calculation for the amount of deferred earn-out consideration in respect of the 12 month period ending on 31 March 2021 (the "Second GSL Reference Period") will remain based on the financial performance of GSL for the Second GSL Reference Period.Β In addition, the GSL deferred earn-out consideration remains payable by the Panoply by the issue of the relevant number of Panoply Shares (calculated in accordance with the GSL SPA) in one tranche following the publication of the Panoply's accounts for the First and Second GSL Reference Period (as applicable).

Β 

SPA for the acquisition of the entire issued share capital of Deeson Group Holdings Limited ("DGHL") dated 18 December 2018 (the "DGHL SPA")

Β 

The maximum total amount of consideration that can be payable under the DGHL SPA has been increased to Β£4,580,000. This a reflection of the strong financial performance of DGHL.

Β 

Agreement between Neal Gandhi and Maxine TolfreyΒ 

Β 

Neal Gandhi ("NG") has entered into an agreement (the "Agreement") with Maxine Tolfrey ("MT") in relation to MT's rights and obligations pursuant to the share purchase agreement for the acquisition of the entire issued share capital of Questers dated 11 May 2018 (the "Questers SPA").Β 

Β 

Pursuant to the Agreement, MT has agreed that she will transfer to NG any further consideration she may receive pursuant to the Questers SPA. The Agreement has been entered into in compliance with the divorce settlement between NG and MT.

Β 

Related party transactions

Β 

The entry into the amendment agreements with the shareholders of FG, Ameo, GSL and DGHL each constitute related party transactions under the AIM Rules for Companies. The Directors of The Panoply (who are all independent in relation to these matters), having consulted with Stifel, consider that the terms of those various amendment agreements are fair and reasonable insofar as the Group's shareholders are concerned.

Β 

Enquiries:

Β 

The Panoply Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

Β 

Stifel Nicolaus Europe Limited

(Nomad and Broker)

Fred Walsh

Alex Price

Β 

Β 

Via Alma PR

Β 

Β 

+44 (0)207 710 7600

Alma PR

(Financial PR)

Susie Hudson

Josh Royston

Harriet Jackson

panoply@almapr.co.uk

+44(0)203 405 0209

Β 

Β 

Β 

Β 

About The Panoply

Β 

The Panoply is a digitally native technology services company, built to service clients' digital transformation needs. Founded in 2016, with the aim of identifying and acquiring best-of-breed specialist information technology, design and innovation consulting businesses, the Group collaborates with its clients to deliver the technology outcomes they're looking for at the pace that they expect and demand.

Β 

The Group is being increasingly recognised as a leading alternative digital transformation provider to the UK public services sector, with c. 70% of its client base representing the public sector and c. 30% representing the commercial sector.

Β 

More information is available at www.thepanoply.com

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGREAANXEENEEAA
Date   Source Headline
11th Dec 20247:00 amRNSShare Incentive Plan
5th Dec 20247:00 amRNSExercise of Options and PDMR Dealings
28th Nov 20247:00 amRNSInterim Results
12th Nov 20247:00 amRNSMajor Contract Win, H1 Update & Notice of Results
11th Nov 20247:00 amRNSShare Incentive Plan
7th Nov 20247:00 amRNSAppointment of Chief Financial Officer
1st Nov 202410:16 amRNSNotification of Major Holdings
10th Oct 20247:00 amRNSShare Incentive Plan
26th Sep 20245:42 pmRNSResult of AGM
16th Sep 20247:00 amRNSDirector/PDMR Shareholding
11th Sep 20241:43 pmRNSShare Incentive Plan
10th Sep 20247:00 amRNSTrading Update
9th Sep 20242:49 pmRNSNotification of Major Holdings
30th Aug 20247:00 amRNSPosting of Annual Report and Notice of AGM
12th Aug 202411:59 amRNSHolding(s) in Company
12th Aug 20249:09 amRNSHolding(s) in Company
12th Aug 20247:00 amRNSShare Incentive Plan
6th Aug 20244:17 pmRNSShare Awards, Exercise of Options & PDMR Dealings
12th Jul 20247:00 amRNSDirector/PDMR Dealing
10th Jul 20247:00 amRNSShare Incentive Plan & Total Voting Rights
9th Jul 20247:00 amRNSPreliminary Results
24th Jun 20247:00 amRNSUpdate on financing arrangements
17th Jun 20247:00 amRNSNotice of Results and Presentations
13th Jun 20244:49 pmRNSTransfer of shares from EBT & Total Voting Rights
13th Jun 20244:38 pmRNSReplacement: Share Incentive Plan & TVR
13th Jun 202412:23 pmRNSNotification of Major Holdings
30th May 202410:45 amRNSCFO Retirement
30th May 20247:00 amRNSTrading Update & Confirmation of Guidance
13th May 20249:45 amRNSShare Incentive Plan & Total Voting Rights
10th Apr 202412:25 pmRNSReplacement: Share Incentive Plan & TVR
10th Apr 20247:00 amRNSShare Incentive Plan & Total Voting Rights
8th Apr 20247:00 amRNSExercise of Options, PDMR Dealings & TVR
3rd Apr 20247:00 amRNSPDMR / PCA Shareholdings
13th Mar 20247:00 amRNSShare Incentive Plan & Total Voting Rights
7th Mar 20243:15 pmRNSHolding(s) in Company
13th Feb 20247:00 amRNSDirector Dealings, Transfer of EBT Shares & TVR
16th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSDirector/PDMR Shareholdings
10th Jan 20247:00 amRNSTransfer of shares from EBT & Total Voting Rights
9th Jan 202410:30 amRNSTPXimpact Certifies as a B Corporation
12th Dec 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
8th Dec 20237:00 amRNSExercise of Options, PDMR Dealings & TVR
5th Dec 20237:00 amRNSInterim Results
10th Nov 20231:34 pmRNSTransfer of shares from EBT & Total Voting Rights
7th Nov 20237:00 amRNSNotice of Results and Presentations
16th Oct 20237:00 amRNSH1 Trading Update & Disposal of TPXimpact Norway
12th Oct 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
28th Sep 202311:00 amRNSResult of AGM
22nd Sep 20237:00 amRNSPDMR Dealings: Grant of share options to Group CEO
18th Sep 20237:00 amRNSSale of Questers for £7.5m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.